Trevi Therapeutics's total assets for Q3 2024 were $68.91M, a decrease of -6.64% from the previous quarter. TRVI total liabilities were $9.94M for the fiscal quarter, a 30.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.